Literature DB >> 2269408

Use of benzhexol hydrochloride to control drooling of children with cerebral palsy.

D Reddihough1, H Johnson, M Staples, I Hudson, H Exarchos.   

Abstract

The use of benzhexol hydrochloride to control drooling was evaluated in a group of 20 children with cerebral palsy. Drooling was measured before treatment and then repeatedly until an optimal dosage of benzhexol hydrochloride was attained. 17 of the 20 children showed an improvement in drooling, and side-effects were minimal. This type of medication appears to be useful in the treatment of drooling.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2269408     DOI： 10.1111/j.1469-8749.1990.tb08121.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN： 0012-1622            Impact factor:   5.449


  6 in total

Review 1.  A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling.

Authors:  P H Jongerius; P van Tiel; J van Limbeek; F J M Gabreëls; J J Rotteveel
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

2.  [Amyotrophic lateral sclerosis: management of bulbar symptoms].

Authors:  P Kraft; M Beck; A Grimm; C Wessig; K Reiners; K V Toyka
Journal:  Nervenarzt       Date:  2010-10       Impact factor: 1.214

Review 3.  [Treatment of sialorrhea with botulinum toxin: an overview].

Authors:  J Hagenah; K G Kahl; S Steinlechner; R Lencer; C Klein
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

4.  Deterioration of feeding behavior following surgical treatment of drooling.

Authors:  R D Stevenson; J H Allaire; P A Blasco
Journal:  Dysphagia       Date:  1994       Impact factor: 3.438

Review 5.  Role of Anesthesiologist in the Management of a Child with Cerebral Palsy.

Authors:  Safiya Imtiaz Shaikh; Ganapati Hegade
Journal:  Anesth Essays Res       Date:  2017 Jul-Sep

Review 6.  Trihexyphenidyl for dystonia in cerebral palsy.

Authors:  Adrienne R Harvey; Louise B Baker; Dinah Susan Reddihough; Adam Scheinberg; Katrina Williams
Journal:  Cochrane Database Syst Rev       Date:  2018-05-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.